Bio-Path Holdings, Inc.
BPTH
$0.14
-$0.005-3.45%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.74% | 33.84% | -2.18% | 7.98% | -32.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.45% | -19.60% | -28.38% | -30.18% | -23.91% |
| Operating Income | 13.45% | 19.60% | 28.38% | 30.18% | 23.91% |
| Income Before Tax | 18.36% | 33.89% | 55.86% | 40.13% | 14.98% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 18.36% | 33.89% | 55.86% | 40.13% | 14.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.36% | 33.89% | 55.86% | 40.13% | 14.98% |
| EBIT | 13.45% | 19.60% | 28.38% | 30.18% | 23.91% |
| EBITDA | 13.62% | 19.24% | 28.15% | 30.30% | 23.87% |
| EPS Basic | 88.40% | 88.98% | 89.10% | 63.17% | 47.02% |
| Normalized Basic EPS | 88.40% | 88.98% | 89.10% | 63.17% | 47.02% |
| EPS Diluted | 88.40% | 88.98% | 89.10% | 63.17% | 47.12% |
| Normalized Diluted EPS | 88.40% | 88.98% | 89.10% | 63.17% | 47.02% |
| Average Basic Shares Outstanding | 603.92% | 499.80% | 305.03% | 62.56% | 60.47% |
| Average Diluted Shares Outstanding | 603.92% | 499.80% | 305.03% | 62.56% | 60.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |